Treatment with azathioprine and cyclic methylprednisolone has little or no effect on bioactivity in anti-interferon beta antibody-positive patients with multiple sclerosis
Gespeichert in:
| Veröffentlicht in: | Multiple sclerosis 2010-12, Vol.16 (12), p.1529-1530 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1530 |
|---|---|
| container_issue | 12 |
| container_start_page | 1529 |
| container_title | Multiple sclerosis |
| container_volume | 16 |
| creator | Bojar, M Zajac, M Meluzínova, E Houžvičková, E Libertinová, J Lišková, P Mat'oška, V Nyč, O Mináriková, M |
| description | |
| doi_str_mv | 10.1177/1352458510382248 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_954600384</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_1352458510382248</sage_id><sourcerecordid>954600384</sourcerecordid><originalsourceid>FETCH-LOGICAL-c348t-3ccc5bdd50490978c41528b46e440a8d749153cd76699f4cff89625d0f3cdac13</originalsourceid><addsrcrecordid>eNqFkU9vFSEUxYmxse3TvStD3LgaCwPMMEvT-C9p4qZdTxi4-GgYGIHRTL-SX1Ker2rSxHQF4fzu4d57EHpJyVtK-_6CMtFyIQUlTLYtl0_QGeV935ChJ0_rvcrNQT9F5znfEkL6noln6LQlsh1azs7Qz-sEqswQCv7hyh6rO1X2Li7JBcAqGKw37Z3GM5T95pcEJrgcfazqXmXsXSkecEw4RAzWgi44Bjy5qHRx313ZsAvVp7jGhQLJQjrIUNTvxymarVlidpUFvKjiaiP52Mm8-uKWap61r1XZ5efoxCqf4cX9uUM3H95fX35qrr58_Hz57qrRjMvSMK21mIwRhA91EVJzKlo58Q44J0qang9UMG36rhsGy7W1cuhaYYitj0pTtkNvjr5Lit9WyGWcXdbgvQoQ1zwOgnekbpw_SkoqhOCcykq-fkDexjWFOsYBogPrak87RI6QrvPmBHasOcwqbSMl4yHw8WHgteTVve86zWD-FvxJuALNEcjqK_z79L-GvwDnhba-</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>815193615</pqid></control><display><type>article</type><title>Treatment with azathioprine and cyclic methylprednisolone has little or no effect on bioactivity in anti-interferon beta antibody-positive patients with multiple sclerosis</title><source>SAGE Complete A-Z List</source><source>MEDLINE</source><creator>Bojar, M ; Zajac, M ; Meluzínova, E ; Houžvičková, E ; Libertinová, J ; Lišková, P ; Mat'oška, V ; Nyč, O ; Mináriková, M</creator><creatorcontrib>Bojar, M ; Zajac, M ; Meluzínova, E ; Houžvičková, E ; Libertinová, J ; Lišková, P ; Mat'oška, V ; Nyč, O ; Mináriková, M</creatorcontrib><identifier>ISSN: 1352-4585</identifier><identifier>EISSN: 1477-0970</identifier><identifier>DOI: 10.1177/1352458510382248</identifier><identifier>PMID: 20829243</identifier><identifier>CODEN: MUSCFZ</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><subject>Antibodies, Neutralizing - blood ; Antibodies, Neutralizing - immunology ; Azathioprine - therapeutic use ; Humans ; Immunosuppressive Agents - therapeutic use ; Indexing in process ; Interferon-beta - immunology ; Interferon-beta - therapeutic use ; Methylprednisolone - therapeutic use ; Multiple Sclerosis, Relapsing-Remitting - blood ; Multiple Sclerosis, Relapsing-Remitting - drug therapy ; Multiple Sclerosis, Relapsing-Remitting - immunology</subject><ispartof>Multiple sclerosis, 2010-12, Vol.16 (12), p.1529-1530</ispartof><rights>The Author(s) 2010</rights><rights>SAGE Publications © Dec 2010</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c348t-3ccc5bdd50490978c41528b46e440a8d749153cd76699f4cff89625d0f3cdac13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/1352458510382248$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1177/1352458510382248$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>314,776,780,21798,27901,27902,43597,43598</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20829243$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bojar, M</creatorcontrib><creatorcontrib>Zajac, M</creatorcontrib><creatorcontrib>Meluzínova, E</creatorcontrib><creatorcontrib>Houžvičková, E</creatorcontrib><creatorcontrib>Libertinová, J</creatorcontrib><creatorcontrib>Lišková, P</creatorcontrib><creatorcontrib>Mat'oška, V</creatorcontrib><creatorcontrib>Nyč, O</creatorcontrib><creatorcontrib>Mináriková, M</creatorcontrib><title>Treatment with azathioprine and cyclic methylprednisolone has little or no effect on bioactivity in anti-interferon beta antibody-positive patients with multiple sclerosis</title><title>Multiple sclerosis</title><addtitle>Mult Scler</addtitle><subject>Antibodies, Neutralizing - blood</subject><subject>Antibodies, Neutralizing - immunology</subject><subject>Azathioprine - therapeutic use</subject><subject>Humans</subject><subject>Immunosuppressive Agents - therapeutic use</subject><subject>Indexing in process</subject><subject>Interferon-beta - immunology</subject><subject>Interferon-beta - therapeutic use</subject><subject>Methylprednisolone - therapeutic use</subject><subject>Multiple Sclerosis, Relapsing-Remitting - blood</subject><subject>Multiple Sclerosis, Relapsing-Remitting - drug therapy</subject><subject>Multiple Sclerosis, Relapsing-Remitting - immunology</subject><issn>1352-4585</issn><issn>1477-0970</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqFkU9vFSEUxYmxse3TvStD3LgaCwPMMEvT-C9p4qZdTxi4-GgYGIHRTL-SX1Ker2rSxHQF4fzu4d57EHpJyVtK-_6CMtFyIQUlTLYtl0_QGeV935ChJ0_rvcrNQT9F5znfEkL6noln6LQlsh1azs7Qz-sEqswQCv7hyh6rO1X2Li7JBcAqGKw37Z3GM5T95pcEJrgcfazqXmXsXSkecEw4RAzWgi44Bjy5qHRx313ZsAvVp7jGhQLJQjrIUNTvxymarVlidpUFvKjiaiP52Mm8-uKWap61r1XZ5efoxCqf4cX9uUM3H95fX35qrr58_Hz57qrRjMvSMK21mIwRhA91EVJzKlo58Q44J0qang9UMG36rhsGy7W1cuhaYYitj0pTtkNvjr5Lit9WyGWcXdbgvQoQ1zwOgnekbpw_SkoqhOCcykq-fkDexjWFOsYBogPrak87RI6QrvPmBHasOcwqbSMl4yHw8WHgteTVve86zWD-FvxJuALNEcjqK_z79L-GvwDnhba-</recordid><startdate>20101201</startdate><enddate>20101201</enddate><creator>Bojar, M</creator><creator>Zajac, M</creator><creator>Meluzínova, E</creator><creator>Houžvičková, E</creator><creator>Libertinová, J</creator><creator>Lišková, P</creator><creator>Mat'oška, V</creator><creator>Nyč, O</creator><creator>Mináriková, M</creator><general>SAGE Publications</general><general>Sage Publications Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7TK</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9-</scope><scope>K9.</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>20101201</creationdate><title>Treatment with azathioprine and cyclic methylprednisolone has little or no effect on bioactivity in anti-interferon beta antibody-positive patients with multiple sclerosis</title><author>Bojar, M ; Zajac, M ; Meluzínova, E ; Houžvičková, E ; Libertinová, J ; Lišková, P ; Mat'oška, V ; Nyč, O ; Mináriková, M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c348t-3ccc5bdd50490978c41528b46e440a8d749153cd76699f4cff89625d0f3cdac13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Antibodies, Neutralizing - blood</topic><topic>Antibodies, Neutralizing - immunology</topic><topic>Azathioprine - therapeutic use</topic><topic>Humans</topic><topic>Immunosuppressive Agents - therapeutic use</topic><topic>Indexing in process</topic><topic>Interferon-beta - immunology</topic><topic>Interferon-beta - therapeutic use</topic><topic>Methylprednisolone - therapeutic use</topic><topic>Multiple Sclerosis, Relapsing-Remitting - blood</topic><topic>Multiple Sclerosis, Relapsing-Remitting - drug therapy</topic><topic>Multiple Sclerosis, Relapsing-Remitting - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bojar, M</creatorcontrib><creatorcontrib>Zajac, M</creatorcontrib><creatorcontrib>Meluzínova, E</creatorcontrib><creatorcontrib>Houžvičková, E</creatorcontrib><creatorcontrib>Libertinová, J</creatorcontrib><creatorcontrib>Lišková, P</creatorcontrib><creatorcontrib>Mat'oška, V</creatorcontrib><creatorcontrib>Nyč, O</creatorcontrib><creatorcontrib>Mináriková, M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>Multiple sclerosis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bojar, M</au><au>Zajac, M</au><au>Meluzínova, E</au><au>Houžvičková, E</au><au>Libertinová, J</au><au>Lišková, P</au><au>Mat'oška, V</au><au>Nyč, O</au><au>Mináriková, M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Treatment with azathioprine and cyclic methylprednisolone has little or no effect on bioactivity in anti-interferon beta antibody-positive patients with multiple sclerosis</atitle><jtitle>Multiple sclerosis</jtitle><addtitle>Mult Scler</addtitle><date>2010-12-01</date><risdate>2010</risdate><volume>16</volume><issue>12</issue><spage>1529</spage><epage>1530</epage><pages>1529-1530</pages><issn>1352-4585</issn><eissn>1477-0970</eissn><coden>MUSCFZ</coden><cop>London, England</cop><pub>SAGE Publications</pub><pmid>20829243</pmid><doi>10.1177/1352458510382248</doi><tpages>2</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1352-4585 |
| ispartof | Multiple sclerosis, 2010-12, Vol.16 (12), p.1529-1530 |
| issn | 1352-4585 1477-0970 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_954600384 |
| source | SAGE Complete A-Z List; MEDLINE |
| subjects | Antibodies, Neutralizing - blood Antibodies, Neutralizing - immunology Azathioprine - therapeutic use Humans Immunosuppressive Agents - therapeutic use Indexing in process Interferon-beta - immunology Interferon-beta - therapeutic use Methylprednisolone - therapeutic use Multiple Sclerosis, Relapsing-Remitting - blood Multiple Sclerosis, Relapsing-Remitting - drug therapy Multiple Sclerosis, Relapsing-Remitting - immunology |
| title | Treatment with azathioprine and cyclic methylprednisolone has little or no effect on bioactivity in anti-interferon beta antibody-positive patients with multiple sclerosis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T06%3A54%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Treatment%20with%20azathioprine%20and%20cyclic%20methylprednisolone%20has%20little%20or%20no%20effect%20on%20bioactivity%20in%20anti-interferon%20beta%20antibody-positive%20patients%20with%20multiple%20sclerosis&rft.jtitle=Multiple%20sclerosis&rft.au=Bojar,%20M&rft.date=2010-12-01&rft.volume=16&rft.issue=12&rft.spage=1529&rft.epage=1530&rft.pages=1529-1530&rft.issn=1352-4585&rft.eissn=1477-0970&rft.coden=MUSCFZ&rft_id=info:doi/10.1177/1352458510382248&rft_dat=%3Cproquest_cross%3E954600384%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=815193615&rft_id=info:pmid/20829243&rft_sage_id=10.1177_1352458510382248&rfr_iscdi=true |